Thyroid hormone resistance syndrome caused by a novel mutation in the thyroid hormone receptor‐beta gene ( THRB , GLU457LYS ) treated with methimazole
Open Access
- 6 November 2022
- journal article
- research article
- Published by Wiley in Clinical Case Reports
- Vol. 10 (11) , e6543
Abstract
A 15‐year‐old girl presented with hyperactivity and behavior disorders. She had tachycardia and no goiter. Thyroid hormones were high and TSH normal. A novel mutation GLU457LYS in THRB gene was observed. Methimazole and propranolol improved clinical symptoms but increased TSH level.Keywords
This publication has 11 references indexed in Scilit:
- Resistance to Thyroid Hormone Beta: A Focused ReviewFrontiers in Endocrinology, 2021
- A new TRβ mutation in resistance to thyroid hormone syndromeHormones, 2016
- Thyroid Hormone Resistance and Its ManagementBaylor University Medical Center Proceedings, 2016
- Methimazole-Induced Goitrogenesis in an Adult Patient With the Syndrome of Resistance to Thyroid HormoneJournal of Investigative Medicine High Impact Case Reports, 2014
- The syndromes of reduced sensitivity to thyroid hormoneBiochimica et Biophysica Acta (BBA) - General Subjects, 2013
- Treatment with Methimazole in a 3-Year-Old Male with Thyroid Hormone ResistanceHormone Research in Paediatrics, 2012
- Case report: thyroid hormone resistance and its therapeutic challengesCurrent Opinion in Pediatrics, 2008
- Thyroid hormone resistanceAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 2006
- Treatment of Resistance to Thyroid Hormone—Primum Non NocereThe Journal of Clinical Endocrinology & Metabolism, 1999
- The Variable Clinical Phenotype in Thyroid Hormone Resistance SyndromeThyroid®, 1994